Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | AMGN | BMY | GILD | VRTX |
| Company | Provention Bio Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 24.99 | 276.00 | 58.00 | 92.40 | 472.31 |
| High | 25.00 | 276.28 | 58.05 | 94.65 | 472.33 |
| Low | 24.98 | 270.58 | 56.62 | 91.94 | 460.74 |
| Last | 24.98 | 273.41 | 56.65 | 92.38 | 468.29 |
| Change | +0.75 | -2.34 | -1.47 | +0.04 | -0.93 |
| % Change | +3.10% | -0.85% | -2.53% | +0.04% | -0.20% |
| Volume | 9,124,100 | 4,493,500 | 10,578,700 | 7,525,400 | 1,043,800 |
| 20-Day Average Volume | 2,505,925 | 4,643,255 | 9,797,375 | 7,208,460 | 1,337,380 |
| Previous Close | 24.23 | 275.75 | 58.12 | 92.34 | 469.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 282.87 | 58.39 | 91.18 | 464.68 |
| 20-Day Raw Stochastic | 98.15% | 31.45% | 17.08% | 73.51% | 43.74% |
| 20-Day Relative Strength | 79.66% | 33.93% | 50.25% | 55.58% | 49.06% |
| Weighted Alpha | +19.60 | -8.22 | +18.42 | +24.53 | +11.33 |
| Today's Opinion | 100% Buy | 88% Sell | 80% Buy | 100% Buy | 8% Sell |
| Previous Opinion | 88% Buy | 72% Sell | 88% Buy | 100% Buy | 8% Sell |
| Last Month's Opinion | 100% Buy | 8% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | -1.74% since 12/04/24 | -2.95% since 12/04/24 | +0.86% since 12/04/24 | +0.93% since 12/04/24 |
| Low | 24.20 on 04/25/23 | 270.58 on 12/11/24 | 56.62 on 12/11/24 | 90.50 on 12/09/24 | 456.86 on 12/06/24 |
| High | 25.00 on 04/26/23 | 280.00 on 12/09/24 | 59.76 on 12/09/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | -15.04% since 11/11/24 | -5.30% since 11/11/24 | -4.79% since 11/11/24 | -6.66% since 11/11/24 |
| Low | 23.82 on 03/27/23 | 257.80 on 11/26/24 | 55.82 on 11/15/24 | 86.08 on 11/19/24 | 445.00 on 11/21/24 |
| High | 25.00 on 04/26/23 | 321.22 on 11/12/24 | 60.68 on 11/25/24 | 96.84 on 11/12/24 | 508.04 on 11/12/24 |
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | -17.14% since 09/11/24 | +16.59% since 09/11/24 | +14.13% since 09/11/24 | -1.36% since 09/11/24 |
| Low | 6.59 on 03/10/23 | 257.80 on 11/26/24 | 47.76 on 09/12/24 | 81.57 on 09/13/24 | 445.00 on 11/21/24 |
| High | 25.00 on 04/26/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | -9.08% since 06/11/24 | +31.68% since 06/11/24 | +42.36% since 06/11/24 | -2.75% since 06/11/24 |
| Low | 6.38 on 10/28/22 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 62.69 on 06/18/24 | 445.00 on 11/21/24 |
| High | 25.00 on 04/26/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 148,224,736 | 117,877,648 | 115,080,200 | 120,837,752 |
| Shares Outstanding, K | 94,781 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 12,900,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -113,570,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 10,810,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -33,280,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 2.47 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 05/04/23 | 02/04/25 | 10/31/24 | 02/04/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 50.18 | 20.45 | 0.00 |